Back to search

Article

Haplotype phasing of <i>CYP2D6</i> : an allelic ratio method using Agena MassARRAY data

2023-03-01

Abstract excerpt

Pharmacogenomics aims to use the genetic information of an individual to personalize drug prescribing. There is evidence that pharmacogenomic testing before prescription may prevent adverse drug reactions, increase efficacy, and reduce cost of treatment. CYP2D6 is a key pharmacogene of relevance to multiple therapeutic areas. Indeed, there are prescribing guidelines available for medications based on CYP2D6 enzym...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ba484006-5bd2-51e2-8973-b9e02cb11689
DOI
10.1101/2023.02.27.530342
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Haplotype phasing of <i>CYP2D6</i> : an allelic ratio method using Agena MassARRAY dataDOI 10.1101/2023.02.27.530342
Select a neighboring publication to make it the new centre.